The effect of SGLT-2 inhibitor switching from TZD with triple combination treatment in type 2 diabetes

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Metabolic and cardio-renal benefits of SGLT2- inhibitors in diabetic patients2024
2. 2Using a SGLT2 inhibitor does not modify the efficacy and tolerability of extended-release metformin in patients with type 2 diabetes2024
3. 3Clinical and laboratory factors associated with response to therapy with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus2024
4. 4Metabolic and renal benefits of using sodium-glucose cotransporter type 2 inhibitors in patients with type 1 diabetes mellitus and continuous subcutaneous insulin infusion2024
5. 5Effect of prior GLP-1 RA treatment on clinical outcomes in patients with type 2 diabetes initiating treatment with tirzepatide2024